Nutrigenomic Medicine Limited
06936539
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/05/2025
total exemption full
Next accounts due
28/02/2027
Confirmation statement
Last: 17/06/2025
Due 01/07/2026
Industry
Officers
director · Since 17/06/2009
CONSULTANT PSYCHOLOGIST
AUSTRALIAN · ENGLAND · Age 65
director · Since 17/06/2009
ECONOMIST
AUSTRALIAN · ENGLAND · Age 70
Also on 1 other board
Persons with Significant Control
Dr Shalleen Mary Barendse
Australian · England · Age 65
Brooklands Farmhouse, Bottle Lane, Bracknell, RG42 5QX
Notified 06/04/2016
Mr Victor Lloyd Barendse
Australian · England · Age 70
Brooklands Farmhouse, Bottle Lane, Bracknell, RG42 5QX
Notified 06/04/2016
CompanyRankvs 1924+ SIC 72110 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2024
Net Worth
£2
Balance sheet strength
Cash
£3k
Cash in the bank
Net Current Assets
-£72k
Working capital
Current Assets
£6k
Current Liabilities
£78k
Fixed Assets
£2k
Debtors
£2k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 0.07 |
| 2023 | 0.17 |
| 2022 | 0.88 |
| 2021 | 0.25 |
| 2020 | 0.27 |
| 2019 | 0.15 |
| 2018 | 0.25 |
Derived from filed accounts. Not audited figures.